Penn Medicine Abramson Cancer Center


 

SOHO 2023 Results from the QuANTUM-First Trial: Impact of allo-HCT in CR1 in Addition to FLT3 Inhibition With Quizartinib in AML With FLT3-Internal Tandem Duplication

0 views
October 17, 2023
Comments 0
Login to view comments. Click here to Login